[13] |
Nouet S,Nahmias C.Signal transduction from the angiotensin Ⅱ AT2receptor[J].Trends Endocrinol Metab,2000,11(1):1-6.
|
[4] |
Tipnis SR,Hooper NM,Hyde R,et al.A human homolog of angiotensin-converting enzyme[J].J Biol Chem,2000,275(43):33238-33243.
|
[1] |
Averill DB,Ishiyama Y,Chappell MC,et al.Cardiac angiotensin-(1-7)in ischemic cardiomyopathy[J].Circulation,2003,108(17):2141-2146.
|
[2] |
Jones ES,Black MJ,Widdop RE.Influence of angiotensin Ⅱ subtype 2 receptor (AT2R)antagonist,PD123319,on cardiovascular remodelling of aged spontaneously hypertensive rats during chronic angiotensin Ⅱ subtype 1 receptor(AT1R)blockade[J].Int J Hypertens,2012,2012:543062.
|
[3] |
Rehman A,Leibowitz A,Yamamoto N,et al.Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats[J].Hypertension,2012,59(2):291-299.
|
[5] |
Gwathmey TM,Pendergrass KD,Reid SD,et al.Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin Ⅱ within the cell nucleus[J].Hypertension,2010,55(1):166-171.
|
[6] |
Giani JF,Miquet JG,Munoz MC,et al.Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice[J].Growth Horm IGF Res,2012,22 (6):224-233.
|
[7] |
Patel VB,Bodiga S,Fan D,et al.Cardioprotective effects mediated by angiotensin Ⅱ type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice[J].Hypertension,2012,59(6):1195-1203.
|
[8] |
Izhak K,Jeffery DM.Molecular pathways underlying cardiac remodeling during pathophysiologic stimulation[J].Circulation,2010,122(25):2727-2735.
|
[9] |
Zile MR,Baicu CF,Stroud RE,et al.Pressure-overload dependent membrane-type 1 matrix metalloproteinase induction:relationship to LV remodeling and fibrosis[J].Am J Physiol,2012,302(7):429-437.
|
[10] |
Anderson J,Vinayak S,Yan FQ,et al.Angiotensin-converting enzyme 2 activation protects against hypertension induced cardiac fibrosis involving extracellular signal-regulated kinases[J].Exp Physiol,2011,96(3):287-294.
|
[11] |
Okayama K,Azuma J,Dosaka N,et al.Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelialmesenchymal transition[J].Hypertension,2012,59(5):958-965.
|
[12] |
Kaschina E,Grzesiak A,Li J,et al.Angiotensin Ⅱ type 2 receptor stimulation:a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?[J].Circulation,2008,118(24):2523-2532.
|
[14] |
Yang J,Chen C,Ren H,et al.Angiotensin Ⅱ AT2receptor decreases AT1receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats[J].J Hypertens,2012,30(6):1176-1184.
|
[15] |
Leung KK,Liang J,Ma MT,et al.Angiotensin Ⅱ type 2 receptor is critical for the development of human fetal pancreatic progenitor cells into islet-like cell clusters and their potential for transplantation[J].Stem Cells,2012,30(3):525-536.
|
[16] |
Ye J,Gimble JM.Regulation of stem cell differentiation in adipose tissue by chronic inflammation[J].Clin Exp Pharmacol Physiol,2011,38(12):872-878.
|
[17] |
Nahmod KA,Walther T,Cambados N,et al.AT1receptor blockade delays postlactational mammary gland involution:a novel role for the renin angiotensin system[J].FASEB J,2012,26(5):1982-1994.
|
[18] |
Hilliard LM,Jones ES,Steckelings UM,et al.Sex-specific influence of angiotensin type 2 receptor stimulation on renal function[J].Hypertension,2012,59(2):409-414.
|
[19] |
Foulquier S,Steckelings UM,Unger T.Impact of the AT2receptor agonist C21 on blood pressure and beyond[J].Curr Hypertens Res,2012,14(5):403-409.
|
[20] |
Verdonk K,Durik M,Abd-Alla N,et al.Compound 21 induces vasorelaxation via an endothelium-and angiotensin Ⅱ type 2 receptor-independent mechanism novelty and significance[J].Hypertension,2012,60(3):722-729.
|
[21] |
Duke LM,Evans RG,Widdop RE.AT2receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1receptor antagonism in conscious normotensive but not hypertensive rats[J].Am J Physiol,2005,288(5):2289-2297.
|
[22] |
Bosnyak S,Welungoda IK,Hallberg A,et al.Stimulation of angiotensin AT2receptors by the non-peptide agonist,compound 21,evokes vasodepressor effects in conscious spontaneously hypertensive rats[J].Br J Pharmacol,2010,159 (3):709-716.
|
[23] |
Matavelli LC,Huang J,Siragy HM.Angiotensin AT2receptor stimulation inhibits early renal inflammation in renovascular hypertension[J].Hypertension,2011,57(2):308-313.
|
[24] |
Schiffrin EL.Vascular remodeling in hypertension:mechanisms and treatment[J].Hypertension,2012,59(2):367-374.
|